Literature DB >> 7092776

Ineffectiveness of methylprednisolone to reduce infarct size in experimental coronary occlusion.

K Genth, M Hofmann, W Schaper.   

Abstract

Two medium-sized branches of the left coronary artery were prepared in each of 10 anesthetized open chest dogs for later occlusion. The first artery was occluded during 90 minutes and reperfused thereafter. This occlusion produced the control infarct. Methylprednisolone (50 mg/kg i.v.) was injected and the second artery was occluded also for 90 minutes and reperfused thereafter. Both infarcts were made visible by staining left ventricular rings with p-nitrobluetetrazolium. Infarct size was compared with the size of the perfusion area, which we obtained from the postmortem angiogram. Both infarcts were equal in size and comprised 50% of the area of perfusion of the occluded artery. Methylprednisolone in a single high dose given prophylactically did not influence infarct size nor any of the measured parameters.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7092776     DOI: 10.1007/BF01908171

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  33 in total

1.  Deleterious effects of methylprednisolone in patients with myocardial infarction.

Authors:  R Roberts; V DeMello; B E Sobel
Journal:  Circulation       Date:  1976-03       Impact factor: 29.690

2.  Protective action of methylprednisolone on the myocardium during experimental myocardial ischemia in the cat.

Authors:  J A Spath; D L Lane; A M Lefer
Journal:  Circ Res       Date:  1974-07       Impact factor: 17.367

3.  Enhanced lysosome fragility in the anoxic perfused guinea pig heart: effects of glucose and mannitol.

Authors:  E Welman; T J Peters
Journal:  J Mol Cell Cardiol       Date:  1977-02       Impact factor: 5.000

4.  Methylprednisolone treatment in acute myocardial infarction. Effect on regional and global myocardial function.

Authors:  J Osher; T W Lang; S Meerbaum; K Hashimoto; J C Farcot; E Corday
Journal:  Am J Cardiol       Date:  1976-03-31       Impact factor: 2.778

5.  Myocardial reperfusion in acute experimental ischemia. Beneficial effects of prior treatment with steroids.

Authors:  P L da Luz; J S Forrester; H L Wyatt; G A Diamond; M Chag; H J Swan
Journal:  Circulation       Date:  1976-05       Impact factor: 29.690

6.  Glucocorticoid protection of the myocardial cell membrane and the reduction of edema in experimental acute myocardial ischemia.

Authors:  M Feola; M Rovetto; R Soriano; S Y Cho; L Wiener
Journal:  J Thorac Cardiovasc Surg       Date:  1976-10       Impact factor: 5.209

7.  Inability of methylprednisolone sodium succinate to decrease infarct size or preserve enzyme activity measured 24 hours after coronary occlusion in the dog.

Authors:  W M Vogel; V G Zannoni; G D Abrams; B R Lucchesi
Journal:  Circulation       Date:  1977-04       Impact factor: 29.690

8.  The influence of reperfusin on infarct size after experimental coronary artery occlusion.

Authors:  M Hofmann; M Hofmann; K Genth; W Schaper
Journal:  Basic Res Cardiol       Date:  1980 Jul-Aug       Impact factor: 17.165

9.  Experimental coronary artery occlusion. I. Measurement of infarct size.

Authors:  W Schaper; H Frenzel; W Hort
Journal:  Basic Res Cardiol       Date:  1979 Jan-Feb       Impact factor: 17.165

10.  NAD glycohydrolase activity in hearts with acute experimental infarction.

Authors:  R Núñez; E Calva; M Marsch; E Briones; F López-Soriano
Journal:  Am J Physiol       Date:  1976-10
View more
  2 in total

Review 1.  Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges.

Authors:  Shuaibo Huang; Nikolaos G Frangogiannis
Journal:  Br J Pharmacol       Date:  2018-03-04       Impact factor: 8.739

2.  Effect of glucocorticoids on arachidonic acid metabolism and prostaglandin secretion by cultures of newborn rat heart cells.

Authors:  E Millanvoye-Van Brussel; M Freyss-Beguin; F Homo-Delarche; D Duval
Journal:  Mol Cell Biochem       Date:  1989 Jun 27-Jul 24       Impact factor: 3.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.